SCOLR Pharma, Inc. - FORM 10-K - EX-32.2 - SECTION 906 CERTIFICATION - March 24, 2010

Attached files

file filename
10-K - FORM 10-K - SCOLR Pharma, Inc.d10k.htm
EX-32.1 - SECTION 906 CERTIFICATION - SCOLR Pharma, Inc.dex321.htm
EX-31.1 - SECTION 302 CERTIFICATION - SCOLR Pharma, Inc.dex311.htm
EX-31.2 - SECTION 302 CERTIFICATION - SCOLR Pharma, Inc.dex312.htm
EX-23.1 - CONSENT OF GRANT THORNTON LLP - SCOLR Pharma, Inc.dex231.htm
EX-10.44 - FORM OF COMMON STOCK PURCHASE WARRANT - SCOLR Pharma, Inc.dex1044.htm
EX-10.40 - LICENSE AGREEMENT - SCOLR Pharma, Inc.dex1040.htm
EX-10.43 - FORM OF UNIT PURCHASE AGREEMENT - SCOLR Pharma, Inc.dex1043.htm
EX-10.41 - AMENDMENT NUMBER THREE TO MANUFACTURE LICENSE AND DISTRIBUTION AGREEMENT - SCOLR Pharma, Inc.dex1041.htm
EX-10.42 - TERM SHEET - SCOLR Pharma, Inc.dex1042.htm

EXHIBIT 32.2

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of SCOLR Pharma, Inc., a Delaware corporation (the “Company”), does hereby certify that:

To my knowledge, the Annual Report on Form 10-K for the year ended December 31, 2009 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

March 24, 2010     By:   /s/ Richard M. Levy
Date       Richard M. Levy,
      Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

Stock widget

Investing forum

SCOLR Pharma, Inc. Reports

Also read